Azilsartan tablets bulk supplier for pharma manufacturers

Azilsartan Tablets 40 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 40 mg

Reference Brands: Edarbi(EU), Takarta(US)

Azilsartan is an angiotensin II receptor blocker (ARB) that prevents angiotensin II from constricting blood vessels, leading to vasodilation. It lowers blood pressure, reduces stroke risk, and supports cardiovascular health. Benefits include effective hypertension control, improved heart function, and long-term protection against cardiovascular events.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Azilsartan Tablets? List it or send an offer →

Product Description: Azilsartan tablets, marketed as Edarbi in the EU and Takarta in the US, are approved for hypertension management. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews detailed clinical trial and quality data for approval, while the EMA ensures compliance with regional safety and quality standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Supporting regional compliance facilitates timely approval, safe use, and global availability of azilsartan tablets, helping patients worldwide control blood pressure and reduce cardiovascular risks effectively.

Azilsartan Tablets — third party manufacturing & bulk supply

Azilsartan Tablets 40 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Azilsartan Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Azilsartan Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Azilsartan Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Azilsartan tablets is listed as Tablets in 40 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Azilsartan tablets is referenced against Edarbi(EU), Takarta(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.